CareDx

CareDx

Yahoo Finance • 27 days ago

10 mid-cap healthcare stocks with the strongest momentum grades

Mid-cap U.S. healthcare stocks have exhibited strong momentum traits year to date, with several names earning A-range momentum grades that indicate stronger price performance trends relative to sector peers. Seeking Alpha's Quant Momentum... Full story

Yahoo Finance • 30 days ago

4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike

Inflation climbed again in August, after easing marginally over the past two months. The latest consumer price index (CPI) print released on Friday shows that the Federal Reserve has ample reasons to go for a rate hike after its September... Full story

Yahoo Finance • 2 months ago

Zacks Industry Outlook CareDx, BrightSpring and PACS

For Immediate Release Chicago, IL – August 25, 2026 – Today, Zacks Equity CareDx, Inc. CDNA, BrightSpring Health Services BTSG and PACS Group, Inc. PACS Industry: Medical Services Link: https://www.zacks.com/commentary/2978701/3-medical... Full story

Yahoo Finance • 2 months ago

Biotech Breakout: What's in focus after Moderna's cancer win?

[mRNA or messenger RNA. The concept of mRNA vaccine. Innovative methods to treat virus. 3d render] Krot Studio INVESTORS SHOULD KNOW: A major Phase 3 trial win from Moderna (MRNA [https://seekingalpha.com/symbol/MRNA]) and Merck (MRK [htt... Full story

Yahoo Finance • 2 months ago

Baron Discovery Fund Gains from Strategic Accumulation of CareDx (CDNA)

Baron Capital, an investment management company, released its Q2 2026 investor letter for the "Baron Discovery Fund". A copy of the letter is available to download here. Baron Discovery Fund appreciated by 19.08% (Institutional Shares) in... Full story

Yahoo Finance • 2 months ago

High-flyer healthcare stocks: Ten names with strong momentum, weak valuations

[Heart Health Concept] Eoneren/E+ via Getty Images Wall Street investors are increasingly seeking refuge in high-performing equity plays as volatile healthcare markets continue to shift, forcing a critical evaluation of stock price veloci... Full story

Yahoo Finance • 2 months ago

Why CareDx Stock Jumped Today

Key Points CareDx is helping to improve outcomes for transplant patients. The health monitor's non-invasive tests are in high demand.10 stocks we like better than CareDx › Shares of CareDx (NASDAQ: CDNA) climbed on Friday after the preci... Full story

Yahoo Finance • 3 months ago

Cathie Wood's Ark Invest boosts stakes in Tesla, SpaceX, Meta, trimming Figma, Shopify

Cathie Wood’s ARK Invest’s largest purchase during July 20-24 was Tesla (TSLA [https://seekingalpha.com/symbol/TSLA]), with the firm acquiring an additional $52.7M stake after a steep sell-off post weaker-than-expected Q2 earnings report.... Full story

Yahoo Finance • 3 months ago

Quant snapshot: Bandwidth and Centene Corporation lead top-rated names as Bank of Marin Bancorp and Axos Financial Dynamics lag

Quant rankings for the upcoming earnings calendar show strength concentrated across information technology, energy, and materials, while weakness is more pronounced in industrials, financials, and real estate. A total of 966 companies are... Full story

Yahoo Finance • 3 months ago

Catalyst watch: Farnborough Air Show, Tesla earnings, AMD AI event, and Samsung reveals

[Skyline of Lower Manhattan] Art Wager Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week. MONDAY - JULY 20... Full story

Yahoo Finance • 3 months ago

Top Biotech Gainers: CDNA Soars On Medicare Policy, ATAI Acquired, ABT Lifts Outlook, APLM On Watch

(RTTNews) - Today's top gainers in the biotech space include CareDx, which rallied after Medicare finalized its Local Coverage Determination process for molecular testing of solid organ allograft rejection; AtaiBeckley, after agreeing to b... Full story

Yahoo Finance • 3 months ago

Cathie Wood reshuffles portfolio ahead of Q2, buys SpaceX, Eli Lilly, Meta; pares AMD, Roku

Cathie Wood's ARK Invest's largest purchase during the last week by value was Elon Musk's Space Exploration Technologies (SPCX [https://seekingalpha.com/symbol/SPCX]), adding a combined 349K shares across ARKK, ARKQ, ARKW and ARKX for ~$52... Full story

Yahoo Finance • 4 months ago

CareDx Reaches Analyst Target Price

In recent trading, shares of CareDx Inc (Symbol: CDNA) have crossed above the average analyst 12-month target price of $25.80, changing hands for $26.18/share. When a stock reaches the target an analyst has set, the analyst logically has... Full story

Yahoo Finance • 5 months ago

Cathie Wood sells $40.6 million of popular semiconductor stock

Cathie Wood, chief of Ark Investment Management, is known for actively trading her holdings, sometimes selling stocks during sharp market pullbacks. Semiconductor stocks experienced a major market pullback on May 15, with the iShares Semi... Full story

Yahoo Finance • 7 months ago

CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference

CareDx logo Key Points Market leadership and solution selling: CareDx said it supports more than 200 transplant centers (~80% of U.S. centers), has performed over 1 million tests, and sees centers using three or more solutions generate r... Full story

Yahoo Finance • 11 months ago

Exploring 3 High Growth Tech Stocks In The US Market

The U.S. stock market recently experienced a rebound, with major indices such as the Nasdaq, Dow Jones Industrial Average, and S&P 500 closing higher amid a recovery from a tech sector downturn and ongoing economic uncertainty due to the g... Full story

Yahoo Finance • 11 months ago

After-Hours Gainers: VCYT, RIGL, NPCE, CDNA, And FBLG Post Notable Moves Following Q3 Results

(RTTNews) - Several healthcare and biotech names posted strong after-hours gains on Tuesday following the release of third-quarter earnings and updated guidance for the remainder of 2025. The session was marked by sharp price movements as... Full story

Yahoo Finance • 11 months ago

CareDx raises 2025 revenue guidance to $372M–$376M with robust RCM gains and new product launches

Earnings Call Insights: CareDx, Inc. (CDNA) Q3 2025 MANAGEMENT VIEW * John Hanna, President and CEO, reported "a strong third quarter on many fronts, including record volume and record revenue in testing services, patient and digital s... Full story

Yahoo Finance • last year

Implied XBI Analyst Target Price: $142

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied... Full story

Yahoo Finance • last year

CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential

CareDx, Inc. (NASDAQ:CDNA) faces fresh uncertainty as proposed reimbursement changes threaten its core testing business, clouding near-term growth even as the company’s expanding transplant solutions platform positions it for long-term opp... Full story